Acute effects of the translocator protein drug ligand FGIN-1-27 on serum testosterone and luteinizing hormone levels in male Sprague-Dawley rats

Fenfen Chen, Hemin Lu, Panpan Chen, Xingxing Zhao, Xiaojui Guan, Qingquan Liang, Barry R Zirkin, Leping Ye, Haolin Chen

Research output: Contribution to journalArticle

Abstract

We reported that FGIN-1-27 (N,N-dihexyl-2-(4-fluorophenyl)indole-3-acetamide, FGIN), a synthetic ligand for translocator protein (TSPO, 18 kDa), increased serum testosterone levels in young and aged Brown Norway rats after its administration daily for 10 days. It is not known, however, how soon after treatment with FGIN serum testosterone rises, how long levels remain elevated after cessation of treatment, or whether the drug acts solely through TSPO. Adult Sprague-Dawley male rats received a single ip dose of FGIN (1 mg/kg BW). Serial blood samples were collected, and serum testosterone and luteinizing hormone (LH) were assessed hourly throughout 24 h. Testosterone concentration was maximal by 3 h, remained significantly higher than the controls at 10 h, and returned to the control level by 24 h. Consistent with the in vivo study, culturing isolated Leydig cells with either FGIN (40 μM) or LH (0.1 ng/ml) resulted in significantly increased testosterone production by 30 min, and the stimulatory effects persisted through 48 h. At a very early (15 min) treatment time, however, FGIN significantly increased testosterone production but LH had not yet done so. Surprisingly, in vivo treatment with FGIN not only increased serum testosterone but also serum LH concentration, raising the possibility that FGIN may increase serum testosterone concentration by dual mechanisms.

Original languageEnglish (US)
Pages (from-to)824-832
Number of pages9
JournalBiology of Reproduction
Volume100
Issue number3
DOIs
StatePublished - Jan 1 2019

Fingerprint

Luteinizing Hormone
Sprague Dawley Rats
Testosterone
Ligands
Serum
Pharmaceutical Preparations
Proteins
Withholding Treatment
N,N-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide
Leydig Cells
Therapeutics

Keywords

  • FGIN-1-27
  • Leydig cell
  • LH
  • Testosterone

ASJC Scopus subject areas

  • Cell Biology

Cite this

Acute effects of the translocator protein drug ligand FGIN-1-27 on serum testosterone and luteinizing hormone levels in male Sprague-Dawley rats. / Chen, Fenfen; Lu, Hemin; Chen, Panpan; Zhao, Xingxing; Guan, Xiaojui; Liang, Qingquan; Zirkin, Barry R; Ye, Leping; Chen, Haolin.

In: Biology of Reproduction, Vol. 100, No. 3, 01.01.2019, p. 824-832.

Research output: Contribution to journalArticle

Chen, Fenfen ; Lu, Hemin ; Chen, Panpan ; Zhao, Xingxing ; Guan, Xiaojui ; Liang, Qingquan ; Zirkin, Barry R ; Ye, Leping ; Chen, Haolin. / Acute effects of the translocator protein drug ligand FGIN-1-27 on serum testosterone and luteinizing hormone levels in male Sprague-Dawley rats. In: Biology of Reproduction. 2019 ; Vol. 100, No. 3. pp. 824-832.
@article{0eda227900c34820a4fcbd2650546a1e,
title = "Acute effects of the translocator protein drug ligand FGIN-1-27 on serum testosterone and luteinizing hormone levels in male Sprague-Dawley rats",
abstract = "We reported that FGIN-1-27 (N,N-dihexyl-2-(4-fluorophenyl)indole-3-acetamide, FGIN), a synthetic ligand for translocator protein (TSPO, 18 kDa), increased serum testosterone levels in young and aged Brown Norway rats after its administration daily for 10 days. It is not known, however, how soon after treatment with FGIN serum testosterone rises, how long levels remain elevated after cessation of treatment, or whether the drug acts solely through TSPO. Adult Sprague-Dawley male rats received a single ip dose of FGIN (1 mg/kg BW). Serial blood samples were collected, and serum testosterone and luteinizing hormone (LH) were assessed hourly throughout 24 h. Testosterone concentration was maximal by 3 h, remained significantly higher than the controls at 10 h, and returned to the control level by 24 h. Consistent with the in vivo study, culturing isolated Leydig cells with either FGIN (40 μM) or LH (0.1 ng/ml) resulted in significantly increased testosterone production by 30 min, and the stimulatory effects persisted through 48 h. At a very early (15 min) treatment time, however, FGIN significantly increased testosterone production but LH had not yet done so. Surprisingly, in vivo treatment with FGIN not only increased serum testosterone but also serum LH concentration, raising the possibility that FGIN may increase serum testosterone concentration by dual mechanisms.",
keywords = "FGIN-1-27, Leydig cell, LH, Testosterone",
author = "Fenfen Chen and Hemin Lu and Panpan Chen and Xingxing Zhao and Xiaojui Guan and Qingquan Liang and Zirkin, {Barry R} and Leping Ye and Haolin Chen",
year = "2019",
month = "1",
day = "1",
doi = "10.1093/biolre/ioy220",
language = "English (US)",
volume = "100",
pages = "824--832",
journal = "Biology of Reproduction",
issn = "0006-3363",
publisher = "Society for the Study of Reproduction",
number = "3",

}

TY - JOUR

T1 - Acute effects of the translocator protein drug ligand FGIN-1-27 on serum testosterone and luteinizing hormone levels in male Sprague-Dawley rats

AU - Chen, Fenfen

AU - Lu, Hemin

AU - Chen, Panpan

AU - Zhao, Xingxing

AU - Guan, Xiaojui

AU - Liang, Qingquan

AU - Zirkin, Barry R

AU - Ye, Leping

AU - Chen, Haolin

PY - 2019/1/1

Y1 - 2019/1/1

N2 - We reported that FGIN-1-27 (N,N-dihexyl-2-(4-fluorophenyl)indole-3-acetamide, FGIN), a synthetic ligand for translocator protein (TSPO, 18 kDa), increased serum testosterone levels in young and aged Brown Norway rats after its administration daily for 10 days. It is not known, however, how soon after treatment with FGIN serum testosterone rises, how long levels remain elevated after cessation of treatment, or whether the drug acts solely through TSPO. Adult Sprague-Dawley male rats received a single ip dose of FGIN (1 mg/kg BW). Serial blood samples were collected, and serum testosterone and luteinizing hormone (LH) were assessed hourly throughout 24 h. Testosterone concentration was maximal by 3 h, remained significantly higher than the controls at 10 h, and returned to the control level by 24 h. Consistent with the in vivo study, culturing isolated Leydig cells with either FGIN (40 μM) or LH (0.1 ng/ml) resulted in significantly increased testosterone production by 30 min, and the stimulatory effects persisted through 48 h. At a very early (15 min) treatment time, however, FGIN significantly increased testosterone production but LH had not yet done so. Surprisingly, in vivo treatment with FGIN not only increased serum testosterone but also serum LH concentration, raising the possibility that FGIN may increase serum testosterone concentration by dual mechanisms.

AB - We reported that FGIN-1-27 (N,N-dihexyl-2-(4-fluorophenyl)indole-3-acetamide, FGIN), a synthetic ligand for translocator protein (TSPO, 18 kDa), increased serum testosterone levels in young and aged Brown Norway rats after its administration daily for 10 days. It is not known, however, how soon after treatment with FGIN serum testosterone rises, how long levels remain elevated after cessation of treatment, or whether the drug acts solely through TSPO. Adult Sprague-Dawley male rats received a single ip dose of FGIN (1 mg/kg BW). Serial blood samples were collected, and serum testosterone and luteinizing hormone (LH) were assessed hourly throughout 24 h. Testosterone concentration was maximal by 3 h, remained significantly higher than the controls at 10 h, and returned to the control level by 24 h. Consistent with the in vivo study, culturing isolated Leydig cells with either FGIN (40 μM) or LH (0.1 ng/ml) resulted in significantly increased testosterone production by 30 min, and the stimulatory effects persisted through 48 h. At a very early (15 min) treatment time, however, FGIN significantly increased testosterone production but LH had not yet done so. Surprisingly, in vivo treatment with FGIN not only increased serum testosterone but also serum LH concentration, raising the possibility that FGIN may increase serum testosterone concentration by dual mechanisms.

KW - FGIN-1-27

KW - Leydig cell

KW - LH

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=85063930548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063930548&partnerID=8YFLogxK

U2 - 10.1093/biolre/ioy220

DO - 10.1093/biolre/ioy220

M3 - Article

C2 - 30299464

AN - SCOPUS:85063930548

VL - 100

SP - 824

EP - 832

JO - Biology of Reproduction

JF - Biology of Reproduction

SN - 0006-3363

IS - 3

ER -